Kimberly Rodriguez
Share |

 

Kimberly Rodriguez

President & CEO, Acessa Health, Inc.

Kim Rodriguez is the President, CEO & Co-Founder of Acessa Health, a privately-held medical device company, developing minimally invasive, uterine sparing solutions for women who suffer from symptomatic uterine fibroids. Previously, she served as President & CEO of Halt Medical.  Prior to Halt, she was Senior Vice President of the Vascular Intervention business unit at Spectranetics, a publicly-traded cardiovascular company acquired by Royal Philips for $2.2B. Kim’s management experience also includes senior leadership positions in sales, marketing and therapy development at Johnson & Johnson, Blockade Medical acquired by Balt International, Concentric Medical acquired by Stryker Neurovascular, Guidant Corporation acquired by Abbott Vascular and Microvena acquired by ev3. Over the course of a 20+ year career in cardiology, radiology, vascular surgery, neurology and women’s health, Kim has been involved in the launch of numerous innovative medtech technologies and M&A transactions. Kim is the co-founder of ATX Women in Medtech, dedicated to enhancing opportunities for women in the medtech industry and involved in the entrepreneurial process. The community focus is on women and enhancing awareness, advocacy and their educational career path. Kim received her Executive MBA at the University of Southern California Marshall School of Business and BS in Management from Pepperdine University.